Third approval in China for AstraZeneca and Daiichi Sankyo’s Enhertu in less than two years
Our centers are performing as expected or even better
Both departments will be equipped with specialized professionals and state-of-the-art facilities ensuring the highest standards of care
Revolutionary technology will further boost OneSource’s scientific services offerings
Finerenone significantly reduced the composite of cardiovascular death and total (first and recurrent) heart failure events compared to placebo in addition to usual therapy
Dr. Vinod Kumar Paul highlighted the huge gap between the demand for and supply of organs
Q1 FY25 revenues up 20% YoY to Rs. 1,002 crore
Performed an autologous bone marrow transplant, using the patient’s own cells to reduce the chances of infection and rejection
These gummies are specially formulated for both kids and adults to nourish the eyes and promote optimal vision development
Subscribe To Our Newsletter & Stay Updated
